Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.13

€2.13

-0.470%
-0.01
-0.470%
-
 
14.01.26 / Tradegate WKN: A40AEG / Name: Pentixapharm Holding / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Pentixapharm Holding AG Stock

Pentixapharm Holding AG shows a slight decrease today, losing -€0.010 (-0.470%) compared to yesterday.

Pros and Cons of Pentixapharm Holding AG in the next few years

Pros
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

EQS-News: Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension
EQS-News: Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension
EQS-News: Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension
EQS-News: Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension
EQS-News: Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension
EQS-News: Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension
EQS-News: Pentixapharm Publishes 9-Month Figures for 2025
EQS-News: Pentixapharm Publishes 9-Month Figures for 2025
EQS-News: Pentixapharm Publishes 9-Month Figures for 2025